• Home
  • Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors.

Author List
Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D
Publication
The Journal of clinical investigation
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1432766
Publication Year
2003
PubMed ID
12727920
Publication Title
Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Invest. 2003 May; 111(9):1287-95.